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TObjective: Donor cause of death may be a risk factor for early mortality after heart
transplantation, but its effect on medium-term survival is uncertain.
Methods: By means of a national prospective database, we investigated the influence of
donor cause of death on survival to 3 years in 1254 adult recipients of cadaveric heart
transplantation between July 1995 and June 2002. Donor cause of death was categorized
a priori as vascular and tumor (group V, n 739), trauma (group T, n 407), hypoxic
(group H, n  82), and infective causes (group I, n  26). Risk factors for early
(30-day), late (30-day to 3-year), and overall mortality were identified with Cox
regression.
Results: Group V donors were more likely to be older (P  .001) and female (P
 .001). There were 297 deaths in the 3-year period, and the unadjusted 3-year
survivals varied significantly (group V 73%, group T 79%, group H 85%, group
I 80%, P  .01). Cox analysis identified donor age, organ ischemia time,
recipient creatinine clearance, recipient diagnosis, peripheral vascular disease,
ventilation, diabetes, and donor-recipient size mismatch as risk factors for early,
late, or overall mortality (P  .10). After adjustment for these factors, donor
cause of death was no longer a significant predictor of recipient death (early
death P  .36, late death P  .79, overall mortality P  .37).
Conclusion: We confirmed that there is an apparent association between cause of
donor death and posttransplantation survival, but this was not maintained after
adjustment for confounding variables. Donor cause of death therefore should not
influence donor organ acceptance or donor-recipient matching and does not identify
marginal donors.
T he quality of the donor heart has an effect on the outcome of heart trans-plantation, as shown by the inferior results when hearts from older ormarginal donors have been used.1 Intracranial vascular events as the donor
cause of death (DCD) may be a risk factor for early mortality after heart transplan-
tation, but there is conflicting evidence regarding the cause of donor brainstem death
on longer-term outcome.2-5 The size and statistical power of some of these reports
may have limited their ability to identify important effects.4
Experimental studies have shown that very abrupt brain death adversely affects
the physiology of the heart, primarily as a result of the catecholamine surge.6,7 The
deleterious effect of brain death on heart function appears to increase with the acuity
of intracranial pressure rise.8,9 In addition, brainstem death results in an inflamma-
tory response, with upregulation of proinflammatory cytokines and adhesion mol-
ecules and rapid leukocyte infiltration. These may exacerbate myocyte injury and
are associated with accelerated acute rejection after heart transplantation in ani-
mals.10 Although there is evidence that DCD is a risk factor for early mortality after
heart transplantation, it is unclear whether this effect is independent of other factors.
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TXMoreover, the nature of DCD may vary among regions and
countries,11 with absence of gunshot wounds to the head in
the United Kingdom.12 To identify variations in DCD in the
United Kingdom and to investigate the influence of DCD on
medium term survival to 3 years, we analyzed data from the
UK Cardiothoracic Transplant Audit database.
Methods
The United Kingdom Cardiothoracic Transplant Audit is a national
prospective cohort study that has been collecting data since April
1995 on all intrathoracic transplantation procedures in the United
Kingdom. Data are collected when patients are registered on the
national waiting list for heart transplantation, at the time of transplan-
tation, and at selected (90 days and yearly thereafter) follow-up
periods. Regular computer-based and on-site case-record validations
are undertaken to ensure accuracy and consistency of data and the
follow-up is 100% complete.
In this study, adult (age 16 years), first-time, isolated heart
recipients undergoing cadaveric donor organ transplantation be-
tween July 1995 and June 2002 were analyzed. The age for
defining pediatric recipients is 16 years in the United Kingdom, as
defined in the “Donor Organ Sharing Scheme—Operating Princi-
ples for Cardiothoracic Transplant Units in the UK and Republic
of Ireland.”13 Survival to 3 years was taken as the primary end
point of the study. DCD was categorized a priori into four cate-
gories: cerebrovascular accidents and brain tumors, cerebral
trauma, hypoxic brain damage, and infective causes.
Donor and recipient characteristics were compared with the 2
test (categorical data) or the Kruskal-Wallis test (continuous vari-
ables). The Kaplan-Meier method was used to derive the survival
estimates. Survival across the DCD groups was compared with the
Wilcoxon-Breslow test. Cox proportional hazards regression anal-
Figure 1. Study pop
TABLE 1. Pretransplantation donor characteristics groupe
Group V (n  739) Group
Age (y, median and IQR) 41 32-48 24
Male (No.) 412 56% 327
Cytomegalovirus positive (No.)* 326 44% 197
Height (cm, median and IQR)* 173 165-180 176
Weight (kg, median and IQR)* 70 65-80 72
Body mass index (kg/m2,
median and IQR)*
24 22-27 23
Group V, Vascular and tumor DCD; Group T, traumatic DCD; Group H, hypo
data.ysis14 was used to identify risk factors for three periods: early
1154 The Journal of Thoracic and Cardiovascular Surgery ● Ma(30-day), late (30-day to 3-year), and overall (3-year) survivals.
These three epochs were chosen to represent clinically meaningful
periods of posttransplantation time and to contain approximately
equal numbers of deaths in each period. The Cox model for each
time period was developed in stages. Potentially important vari-
ables, identified from a clinical review of the database, were first
fitted with a stepwise procedure with a cutoff for variable inclusion
of P  .10. Variables identified in any of the three models were
included in all the models to allow comparison of results in the
different epochs. All analyses were stratified by center size (two
strata) to allow for differing baseline hazard between high- and
low-volume centers. DCD was then added to the model, thereby
allowing us to examine the effect of DCD on survival after
controlling for the variables identified from the stepwise proce-
dure. The proportional hazards assumption was checked for all
models fitted. Results are presented as hazard ratios with 95%
confidence intervals (CIs). Statistical analyses were carried out
with Stata statistical software (release 8.2; Stata Corporation,
College Station, Tex).
Results
A total of 1254 adult recipients undergoing first-time cardiac
transplantation, excluding multiorgan transplantation, from ca-
daveric donors between July 1995 and June 2002 were studied.
There were 739 (59%) heart transplants from donors who died
of vascular and tumor-related causes, 407 (32%) from donors
who died after trauma, 82 (7%) from donors who died of
hypoxic brain injury (including drug overdose), and 26 (2%)
from donors with infective causes of death (Figure 1). Detailed
causes of death for donors assigned to each of the four groups
are given in Appendix Table 1. Brain tumor as DCD consti-
n and DCD groups.
DCD
 407) Group H (n  82) Group I (n  26) P value
19-34 26 20-37 22 18-33 .001
80% 42 51% 20 77% .001
49% 26 32% 9 35% .02
70-182 172 165-180 177 170-180 .001
65-80 70 60-80 75 59-87 .3
22-25 23 21-26 24 20-26 .003
D; Group I, infective DCD; IQR, interquartile range. *Less than 1% missingulatiod by
T (n
1
xic DCtuted 5% of the V group.
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Donor and pretransplantation recipient characteristics were
compared across the four groups, and some differences were
found (Tables 1 and 2). Donors dying of vascular and tumor
causes were significantly older than donors dying of other
causes (P  .001), and the trauma and infective groups had a
higher proportion of male donors than the other groups
(P .001). Also, donors in these groups were taller (P .001)
and had a lower body mass index (P .003) than those in the
other two groups. Significantly fewer donors dying of hypoxic
brain damage or infective causes had positive antibodies for
cytomegalovirus than in the other groups.
The proportion of male recipients was higher in the vascular
TABLE 2. Pretransplantation recipient characteristics grou
Group V (n  739) Group
Recipient age at transplantation
(median and IQR)
52 45-57 51
Male recipient (No.) 614 83% 346
Recipient height (cm, median
and IQR)*
173 167-178 174
Recipient weight (kg, median
and IQR)
75 66-85 76
Recipient body mass index (kg/
m2, median and IQR)
25 23-28 26
Previous heart operations
(No.)*
254 34% 105
Serum creatinine (mol/L,
median and IQR)*
116 98-136 118
Creatinine clearance (mL/min,
median and IQR)*
71 56-87 71
Inpatient at transplantation 162 22% 78
Inotropes at transplantation* 103 14% 52
Intra-aortic balloon pump at
transplantation*
28 4% 11
Group V, Vascular and tumor DCD; Group T, traumatic DCD; Group H, hypo
data.
TABLE 3. Recipient causes of death in the DCD cohorts
Cause of death Group
Cardiac failure (including rejection and cardiac
allograft vasculopathy)
48 (25%
Early graft failure* 57 (29%
Hemorrhage including gastrointestinal hemorrhage 11 (6%
Infection 27 (14%
Embolism or infarction 14 (7%
Multiorgan failure 13 (6%
Malignancy 4 (2%
Other causes of death 9 (5%
Cause of death unknown 13 (6%
Total 196 (100
Group V, Vascular and tumor DCD; Group T, traumatic DCD; Group H, hy
admission for transplantation.and trauma groups, but not significantly so (P .06). Previous
The Journal of Thoracicheart surgery, defined as any procedure where the use of
cardiopulmonary bypass was employed, was more common
among recipients in the vascular and hypoxic brain injury
groups (P  .02). All other factors were distributed similarly
across the four groups.
At analysis, 297 (24%) patients had died, and the overall
3-year survival for the whole cohort was 75% (95% CI
73%-78%). The causes of death for recipients did not differ
among the DCD cohorts (2 test, P  .7; Table 3). The
median follow-up for survivors was 36 months. Unadjusted
Kaplan-Meier survival estimates by DCD are shown in
Figure 2. Three-year survival differed significantly across
by DCD
 407) Group H (n  82) Group I (n  26) P value
42-56 50 42-55 51 48-56 .2
85% 60 73% 20 77% .06
68-179 172 165-176 175 165-178 .08
67-86 76 65-83 79 68-89 .5
23-28 26 23-28 26 23-30 .5
26% 26 32% 7 27% .02
98-141 112 100-137 129 100-169 .4
57-90 68 56-90 62 53-87 .7
19% 18 22% 5 19% .7
13% 11 13% 3 12% .9
3% 4 5% 1 4% .5
D; Group I, infective DCD; IQR, interquartile range. *Less than 1% missing
Group T Group H Group I Total
16 (19%) 1 (8%) 1 (20%) 66 (22%)
23 (28%) 5 (42%) 1 (20%) 86 (29%)
3 (3%) 0 (0%) 0 (0%) 14 (5%)
10 (13%) 2 (17%) 1 (20%) 40 (13%)
3 (3%) 0 (0%) 0% 17 (6%)
11 (13%) 2 (17%) 0% 26 (9%)
3 (3%) 1 (8%) 0% 8 (3%)
9 (11%) 1 (8%) 1 (20%) 20 (7%)
6 (7%) 0 (0%) 1 (20%) 20 (7%)
84 (100%) 12 (100%) 5 (100%) 297 (100%)
DCD; Group I, infective DCD. *Deaths due to donor organ failure in thatped
T (n
1
xic DCV
)
)
)
)
)
)
)
)
)
%)
poxicthe groups (P  .01). Recipients of hearts from donors who
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survival (73%, 95% CI 69%-76%), and survival was highest
in the hypoxic brain injury group (85%, 95% CI 75%-91%).
Three-year survival of recipients with hearts from the trau-
matic group was 79% (95% CI 74%-83%).
Stepwise Cox regression analysis identified donor age
(grouped 25 years, 26-40 years, 41-55 years, 55 years),
organ ischemia time (grouped 120 minutes, 121-180 min-
utes, 181-240 minutes, 240 minutes), recipient creatinine
clearance at transplant (50 mL/min), recipient diagnosis
(grouped ischemic cardiomyopathy, dilated cardiomyopathy,
congenital cardiac disease, other cardiac diseases), history of
peripheral vascular disease in the recipient, recipient ventila-
tion before or at the time of transplantation, diabetes (in the
donor and in the recipient), drug abuse in the donor, and
donor-recipient size mismatch (ratio of donor to recipient body
surface area 0.80) as risk factors for early, late, or overall
mortality (P  .10). Estimated hazard ratios for recipient
factors and DCD are given in Table 4 and those for donor
factors and DCD are given in Table 5. Preoperative ventilation
was included only in the early (30-day) survival model, be-
cause all recipients with preoperative ventilation died within 30
Figure 2. Unadjusted Kaplan-Meier sudays of transplantation. After adjustment for the factors iden-
1156 The Journal of Thoracic and Cardiovascular Surgery ● Matified from the stepwise analyses, DCD was no longer a sig-
nificant predictor of recipient death (early death P  .36, late
death P  .79, overall mortality P  .37).
The proportional hazards assumption was checked for
the three models. The overall test for each model suggested
that the assumption was reasonable (test for nonproportion-
ality P  .22, P  .29, and P  .69 for overall, 30-day, and
30-day to 3-year models, respectively).
Discussion
Unlike previous studies, we have found that the apparent
association between DCD and recipient survival does not
persist after adjustment for other covariates. In keeping with
previous studies, the donor organ characteristics that deter-
mine early outcome are donor age, ischemia time, and size
mismatch.1,15 After the initial 30 posttransplantation days,
the only donor factor determining 3-year outcome is donor
age. Some earlier studies have reported an association be-
tween DCD and posttransplantation survival.3,5,10 Tsai and
colleagues3 compared outcomes in heart transplant recipi-
ents of donors with traumatic and atraumatic intracranial
bleeding. They found significantly worse early posttrans-
l estimates by DCD groups (P  .01).rvivaplantation survival in the atraumatic group but no difference
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univariate and multivariate analysis in a multicenter study,
found better medium-term (2-year) survival with hearts
from donors who died of intracranial injury than with those
who died of cerebral hemorrhage.
In experimental studies, myocardial injury after brain-
stem death varies significantly with the type and duration of
brain injury.8,16 Our a priori classification of DCD (vascular
and tumor, trauma, hypoxic brain damage, and infection)
assumed different pathophysiologic mechanisms of brain-
stem death in the different groups. As in previously pub-
lished reports, we assumed that donors in the two larger
categories (vascular and tumor and trauma) might experi-
ence a different acuity of brainstem death. The hypoxic
brain injury and infection (predominantly meningitis)
groups were considered separately because their pathophys-
iologic characteristics could not be presumed to be similar
to those of the major groups. In the United Kingdom, most
posttrauma donors are killed in motor vehicle crashes (there
were no gunshot wounds to the head in this series). These
donors potentially have a more rapid development of intra-
cranial pressure than those in the vascular and tumor group
TABLE 4. Recipient risk factors for early (<30-day), late (
Risk factor
Early
Hazard ratio 95% CI P value
Creatinine clearance 1.88 1.29-2.73 .001
Diabetes mellitus 2.21 1.38-3.53 .001
Ventilation* 2.43 0.98-6.03 .06
Peripheral vascular disease 3.30 1.50-7.27 .003
Diagnosis group
Ischemic cardiomyopathy 1 — .01
Dilated cardiomyopathy 0.83 0.57-1.20
Congenital heart disease 2.73 1.36-5.46
Other heart disease 1.08 0.65-1.79
*Inestimable hazard ratios.
TABLE 5. Donor risk factors for early (<30-day), late (30-d
Risk factor
Early
Hazard ratio 95% CI P value H
DCD
Vascular and tumor 1 — .4
Trauma 0.76 0.50-1.16
Hypoxic brain injury 0.57 0.25-1.33
Infective 0.54 0.13-2.22
Donor age group* 1.24 0.99-1.53 .05
Donor drug abuse† 0.74 0.23-2.37 .2
Donor diabetes† 1.11 0.27-4.58 .1
Size mismatch 2.95 1.19-7.31 .02
Organ ischemia time 1.36 1.13-1.64 .001*Increase in each age group. †Adjusted for missing values.
The Journal of Thoracicand also could have been expected to include a significant
fraction of donors with multiple injures. We included do-
nors who died of tumor in the vascular group on the as-
sumption that they would have a single organ process and a
similar timescale of brainstem death development. A post
hoc analysis revealed near identical results when donors
with vascular cause of death were considered separately.
In this study, donors dying of vascular accidents and brain
tumors were significantly older than other donors. Posttrauma
donors were younger, more likely to be male, and taller than
donors from other groups, with a lower body mass index.
These factors (age, sex, and size) are potentially advantageous
for the outcome in the trauma group and, we believe, led to the
improved unadjusted survival. This apparent association be-
tween DCD and survival after heart transplantation was not
confirmed after adjustment for donor- and recipient-related
confounding factors. Importantly, this cohort did not include
any patients with extremely acute trauma from gunshot
wounds to the head. The latter group could have a different
pathophysiology and acuity of brainstem death, which could
influence survival. We also found statistically significant dif-
ferences on univariate analysis in donor cytomegalovirus status
y to 3-year), and overall survivals
Late Overall
ard ratio 95% CI P value Hazard ratio 95% CI P value
1.04 0.67-1.62 .9 1.43 1.08-1.90 .01
0.78 0.38-1.60 .5 1.48 1.01-2.19 .05
— — — — — —
0.53 0.07-3.81 .5 1.93 0.94-3.95 .07
1 — .1 1 — .03
0.76 0.53-1.10 0.79 0.61-1.02
0.51 0.12-2.12 1.58 0.86-2.89
1.34 0.84-2.15 1.20 0.85-1.69
o 3-year), and overall survivals
Late Overall
ratio 95% CI P value Hazard ratio 95% CI P value
— .8 1 — .4
4 0.70-1.55 0.88 0.66-1.18
7 0.29-1.56 0.61 0.34-1.12
7 0.33-3.45 0.73 0.30-1.81
0 1.06-1.62 .01 1.26 1.09-1.47 .002
1 0.69-3.74 .2 1.12 0.57-2.22 .09
6 0.18-3.13 .5 0.92 0.34-2.51 .07
0 0.07-3.58 .5 1.63 0.72-3.69 .2
6 0.97-1.40 .1 1.26 1.10-1.43 .00130-da
Hazay t
azard
1
1.0
0.6
1.0
1.3
1.6
0.7
0.5
1.1and Cardiovascular Surgery ● Volume 129, Number 5 1157
Cardiothoracic Transplantation Ganesh et al
TXand in the history of previous open heart operations in recipi-
ents. These findings are difficult to explain and may represent
type I statistical errors.
This study is based on a multicenter national cohort of
patients with 100% data accrual and follow-up. The end
point of survival is robust and validated. However, we were
not able to validate a timescale for donor brainstem death,
and we recognize that this may be important. Although the
study represents a retrospective analysis, the data were
accrued prospectively. We were not able to assess the se-
verity of the rejection episodes or development of graft
vasculopathy, because the database was set up to collect a
limited number of variables for audit purposes. The differ-
ences in transplantation volume among the centers was
allowed for in the proportional hazards model.
In conclusion, although there is an apparent association
between DCD and posttransplantation survival, it is not
maintained after adjustment for confounding variables.
DCD was not an independent risk factor for mortality as late
as 3 years after heart transplantation in this national cohort.
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Appendix
TABLE 1. Individual DCDs by DCD group
Cause of death No. %
Cause of death in vascular and tumor group
(n  739)
Intracranial hemorrhage 628 85%
Intracranial thrombosis 22 3%
Brain tumor 37 5%
Intracranial, type unclassified
(cerebrovascular accident)
41 6%
Aneurysm 10 1%
Liver failure (not self-poisoning) 1 —
Cause of death in trauma group (n  407)
Trauma, road traffic accident, car 98 24%
Trauma, road traffic accident, motorbike 48 12%
Trauma, road traffic accident, bicycle 28 7%
Trauma, road traffic accident, pedestrian 73 18%
Trauma, road traffic accident, unknown type 41 10%
Other trauma, accident 96 24%
Other trauma, unknown cause 23 5%
Cause of death in hypoxic brain injury group
(n  82)
Hypoxic brain damage, all causes 33 40%
Other trauma, suicide 25 30%
Cardiac arrest 4 5%
y 2005
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Asthma 3 4%
Respiratory failure 3 4%
Carbon monoxide poisoning 5 6%
Respiratory type unclassified, including
smoke inhalation
1 1%
Acetaminophen (INN: paracetamol) 1 1%The Journal of ThoracicCause of death No. %
Other drug overdose 7 9%
Cause of death in infective group (n26)
Meningitis 19 73%
Septicemia 1 4%
Infections, type unclassified 6 23%TXoverdoseand Cardiovascular Surgery ● Volume 129, Number 5 1159
